Another in vitro study also found that supplementation of exogenous SCGB1a1 can reverse cigarette smoke-induced IL-8 release and attenuate airway inflammation in biopsy specimens from patients with COPD (64). This evidence concerns the gene SCGB1A1 and chronic obstructive pulmonary disease.